Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 Jun;62(6):564-8.
doi: 10.1136/adc.62.6.564.

Comparison of four pancreatic extracts in cystic fibrosis

Clinical Trial

Comparison of four pancreatic extracts in cystic fibrosis

D W Beverley et al. Arch Dis Child. 1987 Jun.

Abstract

Four different pancreatin products, Pancrease, Creon, Pancrex V Forte, and Pancreatin Merck, were compared in a random crossover trial in children with cystic fibrosis. The results of our study showed that patients who received Creon and Pancrease had fewer gastrointestinal symptoms than patients who received Pancrex V Forte and Pancreatin Merck. Fat absorption was significantly improved with Pancrease when compared with Pancrex V forte and Pancreatin Merck. Also the fat absorption with Creon was superior to that with Pancrex V Forte. There was no significant difference in fat absorption between Pancrease and Creon. Pancrex V Forte and Pancreatin Merck, or Pancreatin Merck and Creon. Faecal nitrogen content was less with both Creon and Pancrease compared with Pancreatin Merck. Creon and Pancrease allow the patient with cystic fibrosis to take a high energy diet without any dietary restrictions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pediatrics. 1959 Aug;24(2):313-21 - PubMed
    1. J Pediatr. 1974 Mar;84(3):328-34 - PubMed
    1. Br Med J. 1968 Feb 17;1(5589):407-9 - PubMed
    1. Dig Dis Sci. 1979 Dec;24(12):906-9 - PubMed
    1. J Pediatr. 1978 Dec;93(6):976-8 - PubMed

Publication types